Latest Capital Raising News

Warriedar Resources has confirmed significant high-grade antimony mineralisation at its Azure Coast deposit near the Ricciardo gold project, unveiling new potential in the Golden Range belt. The company plans targeted drilling later this year to expand on these promising results.

Power Minerals Limited has launched a new options offer linked to a recent $1.3 million placement, alongside updates on key project acquisitions and divestments. The prospectus outlines significant risks and strategic directions as the company navigates growth and financial challenges.

Olympio Metals has raised $1.6 million through a share placement and director subscription to fund ongoing drilling at its promising Bousquet Gold Project and nearby Dufay Copper-Gold Project in Quebec, Canada.

Enterprise Metals Ltd is set to raise approximately $780,000 through a share placement aimed at advancing drilling activities across its key Western Australian projects.

Staude Capital Global Value Fund Limited (GVF) has responded to ASX concerns over a media article revealing details of its capital raising before official announcement, denying any direct media disclosures and reaffirming its compliance policies.

Trigg Minerals Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant capital raise, signaling potential shifts in its financial strategy.

Investigator Resources appoints Lachlan Wallace as Managing Director and secures $4.3 million to accelerate exploration at the Paris Silver Project and beyond.

Red Mountain Mining has successfully raised $0.65 million through a heavily oversubscribed placement, enabling accelerated exploration at its Armidale Antimony-Gold Project and other gold assets in Australia and Canada.

Wide Open Agriculture Limited reminds shareholders of the imminent closing of its Securities Purchase Plan, offering shares at a discounted price with free options, while gearing up for an investor webinar to discuss company progress.

archTIS Limited has secured A$7.5 million through a discounted share placement to fund expansion in the U.S. defence sector, deepen strategic partnerships, and accelerate product innovation focused on secure data collaboration.

Prescient Therapeutics has launched a $7 million Share Purchase Plan at a notable discount to fund the next phase of clinical trials for its promising PTX-100 cancer therapy. The capital raise aims to accelerate progress toward regulatory approval and patient access.

Challenger Gold Limited advances its Hualilan Gold Project towards early production via a toll milling agreement starting in late 2025, underpinned by a robust 2.8 million ounce gold equivalent resource and strong project economics.